Novel purine derivatives show significant antiviral activity against enterovirus through a mechanism independent of phosphatidylinositol 4-kinase KIIIβ inhibition.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for enterovirus antivirals via novel mechanisms; leaves open targets pending human validation.
The synthesis of a novel library of purine derivatives bearing various bicyclic and polycylic substituents at the N-9 position is described. The series includes norbornanes, bicyclo[2.2.2]octanes, and bicyclo[3.2.1]octanes attached at the bridgehead position as well as bicyclo[3.1.1]heptanes, tetrahydro-1-naphthalenes, and adamantanes bonded either directly or via a linear chain to the 6-chloropurine nucleobase. A number of prepared derivatives exerted significant activity against the enterovirus. Despite attempts to correlate the activity against picornaviruses with their phosphatidylinositol 4-kinase KIIIβ inhibitory activity, it is clear that the inhibition of this host factor cannot explain the observed antiviral potency.
No takes yet. Share an insight, caveat, or question.
Dejmek et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: